AdvanSix Inc.
NYSE:ASIXChemicals
-$0.89 today
- Market cap
- $380.01M
- Beta
- 1.29
- P/E (TTM)
- 51.6
- EPS (TTM)
- $0.39
- Dividend yield
- 3.22%
Volume 0.43M
Average 0.37M
ASIX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
AdvanSix Inc.NYSE: ASIX
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.6% of revenue in FY2025, up 0.6 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 8.7M USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.7M | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How ASIX compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for ASIX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $10.63M USD | +195.4% | -36.2% | 6.1% | |
ADURAduro Clean Technologies Inc. | LTM Feb 2026 | CA$7.36M CAD | +38.8% | +73.9% | 3044.1% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | +7.7% | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding ASIX) | — | -30.6% | +7.7% | 0.0% | |
Competitors are the stored peer set for ASIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.68B | 1.95B | 1.53B | 1.52B | 1.52B |
| Cost of Revenue | 1.41B | 1.63B | 1.37B | 1.36B | 1.35B |
| Gross Profit | 274.12M | 314.48M | 165.09M | 152.94M | 173.64M |
| Gross Margin | 16.3% | 16.2% | 10.8% | 10.1% | 11.4% |
| Research & Development | 0 | 0 | 0 | 0 | 8.7M |
| Selling, General & Admin | 82.99M | 87.75M | 95.54M | 94.02M | 97.43M |
| Operating Expenses | 82.99M | 87.75M | 95.54M | 94.02M | 106.13M |
| Depreciation & Amortization | 65.34M | 69.35M | 73.01M | 76.18M | 79.74M |
| EBITDA | 255.48M | 297.93M | 149.72M | 133.06M | 142.65M |
| EBITDA Margin | 15.2% | 15.3% | 9.8% | 8.8% | 9.4% |
| Operating Income | 191.14M | 226.73M | 69.55M | 58.91M | 67.52M |
| Operating Margin | 11.3% | 11.7% | 4.5% | 3.9% | 4.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.02M | 2.78M | 7.49M | 11.31M | 8.48M |
| Other Income / Expenses | (6.02M) | (940K) | (327K) | (13.34M) | (13.08M) |
| Income Before Tax | 185.12M | 225.79M | 69.22M | 45.58M | 54.43M |
| Pre-Tax Margin | 11.0% | 11.6% | 4.5% | 3.0% | 3.6% |
| Income Tax Expense | 45.33M | 53.91M | 14.6M | 1.43M | 5.15M |
| Net Income | 139.79M | 171.89M | 54.62M | 44.15M | 49.29M |
| Net Margin | 8.3% | 8.8% | 3.6% | 2.9% | 3.2% |
| EPS (Basic) | 4.97 | 6.15 | 2.00 | 1.65 | 1.83 |
| EPS (Diluted) | 4.81 | 5.92 | 1.95 | 1.62 | 1.80 |
| Weighted Avg Shares | 28.15M | 27.97M | 27.3M | 26.83M | 26.9M |
| Weighted Avg Shares (Diluted) | 29.05M | 29.03M | 28.01M | 27.26M | 27.33M |
AdvanSix Inc.
NYSE:ASIX
Intrinsic Alpha fair value
Locked
Current Price
$14.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.